Petach-Tikva, Israel

Brainstorm Cell Therapeutics Ltd.


USPTO Granted Patents = 7


Forward Citations = 25

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Avinoam Kadouri (4 out of 6 patents)

silverMedal Avihay Bar-Ilan (4 out of 5 patents)

bronzeMedal Eldad Melamed (4 out of 24 patents)

4.  Ofer Sadan (4 out of 5 patents)

5.  Merav Bahat-Stromza (4 out of 8 patents)

6.  Daniel Offen (4 out of 23 patents)

7.  Yael Gothelf (3 out of 3 patents)

8.  Yosef Levy (2 out of 2 patents)

9.  Alex Burshtein (1 out of 1 patent)

10.  Jonathan Semo (1 out of 1 patent)

11.  Haggai Kaspi (1 out of 1 patent)

12.  Revital Aricha (1 out of 1 patent)


7 patents:

Company Overview
BrainStorm Cell Therapeutics Ltd. is a biotechnology company focused on developing innovative adult stem cell therapies for neurodegenerative diseases such as ALS and multiple sclerosis. Their lead product candidate, NurOwn, is currently in Phase 3 clinical trials and has shown promising results in early studies. With a strong commitment to research and development, BrainStorm aims to provide new treatment options for patients with debilitating neurological disorders.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Brainstorm Cell Therapeutics Ltd. USPTO Patent Assignee Logo
7 Patents

#35 in Petach-Tikva

#911 in Israel

Petach-Tikva, IL
Petach-Tikva, Israel
Forward Citations = 25

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Brainstorm Cell Therapeutics Ltd.. Retrieved from https://idiyas.com/company/brainstorm-cell-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…